You are here
,

Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value

  • Sunday, 24 March 2019
  • Posted by Aftab Ahmad
  • 1 Comments
Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer's disease drug aducanumab, a major setback in the quest to find a treatment for the mind-wasting disease and a blow to Biogen, which lost more than $18 billion of its value on Thursday.


from Reuters: Health News https://ift.tt/2TqjEF8

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

1 comments:

  1. Jatin Sethi5 June 2020 at 09:43

    You ought to consistently ensure that the rehab focuses you are inquiring about are staffed by experts who are affirmed in rehab treatment, and that the middle itself is guaranteed. In spite of the fact that there are numerous methods of rewarding habit, there are absolutely some that are more regarded and more effective than others, and you should ensure that the treatment you will get follows in accordance with what is for the most part thought to work in the clinical business.
    inspirational quotes for addiction
    inspirational quotes for addicts
    beating addiction quotes
    motivational recovery quotes

    ReplyDelete